FDA Green Lights SonarMed's Device for Monitoring Newborns

Houston-area biotech SonarMed has received FDA clearance to sell its non-invasive medical device that can monitor, in real-time, endotracheal tube position in newborn babies—and help guard against suffocation.

The company previously received regulatory approval for a version of the device used on adult patients since 2012. Executives didn’t disclose details on sales.

Back to news